SUBSCRIBE
2 minutes
Invizius, an Edinburgh-based biotech company pioneering treatments for dialysis patients, has secured £950,000 in funding. The funding round was led by Mercia Ventures and supported by Calculus Capital, Syensqo, the University of Edinburgh's Old College Capital, and Scottish Enterprise.
